Lipella Pharmaceuticals Common Stock Alpha and Beta Analysis
| LIPO Stock | 3.11 0.16 5.42% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lipella Pharmaceuticals Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lipella Pharmaceuticals over a specified time horizon. Remember, high Lipella Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lipella Pharmaceuticals' market risk premium analysis include:
Beta 1.47 | Alpha (0.23) | Risk 7.97 | Sharpe Ratio 0.0244 | Expected Return 0.19 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lipella |
Lipella Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lipella Pharmaceuticals market risk premium is the additional return an investor will receive from holding Lipella Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lipella Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lipella Pharmaceuticals' performance over market.| α | -0.23 | β | 1.47 |
Lipella Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lipella Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Lipella Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Lipella Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Lipella Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lipella Pharmaceuticals shares will generate the highest return on investment. By understating and applying Lipella Pharmaceuticals stock market price indicators, traders can identify Lipella Pharmaceuticals position entry and exit signals to maximize returns.
Lipella Pharmaceuticals Return and Market Media
The median price of Lipella Pharmaceuticals for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 3.27 with a coefficient of variation of 13.23. The daily time series for the period is distributed with a sample standard deviation of 0.43, arithmetic mean of 3.23, and mean deviation of 0.32. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Lipella Pharmaceuticals announces board election and reverse stock split - Investing.com India | 09/12/2024 |
2 | Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit | 10/09/2024 |
3 | Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group | 11/21/2024 |
About Lipella Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lipella or other stocks. Alpha measures the amount that position in Lipella Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2023 | 2024 (projected) | Current Ratio | 5.31 | 8.9 | 9.34 | Net Debt To EBITDA | 1.81 | 0.69 | 0.65 |
Lipella Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Lipella Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lipella Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Lipella Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Lipella Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Lipella Pharmaceuticals' management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Lipella Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Lipella Pharmaceuticals Backtesting, Lipella Pharmaceuticals Valuation, Lipella Pharmaceuticals Correlation, Lipella Pharmaceuticals Hype Analysis, Lipella Pharmaceuticals Volatility, Lipella Pharmaceuticals History and analyze Lipella Pharmaceuticals Performance. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Lipella Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.